Safety and efficacy of irreversible electroporation as an ablative method of cancer treatment (2018-2019)

   BI-US/18-19-002
USA partner: Govind S. Srimathveeravalli, Memorial Sloan-Kettering Cancer Center, New York, USA
Slovenian partner: Prof. Dr. Damijan Miklavčič, University of Ljubljana, Faculty of Electrical Engineering
Funding: Slovenian Research Agency (ARRS), Slovenia

 

The project is funded by the Slovenian Research Agency (ARRS).